Katherine K. Perez
Pfizer (United States)(US)
Publications by Year
Research Areas
Antibiotic Use and Resistance, Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing, Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus
Most-Cited Works
- → Integrating Rapid Pathogen Identification and Antimicrobial Stewardship Significantly Decreases Hospital Costs(2012)381 cited
- → Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia(2014)315 cited
- → Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma(2020)294 cited
- → Review of Rapid Diagnostic Tests Used by Antimicrobial Stewardship Programs(2014)253 cited
- → PBP2a Mutations Causing High-Level Ceftaroline Resistance in Clinical Methicillin-Resistant Staphylococcus aureus Isolates(2014)146 cited
- → Integrating Rapid Diagnostics and Antimicrobial Stewardship in Two Community Hospitals Improved Process Measures and Antibiotic Adjustment Time(2016)77 cited
- → Role of Rapid Diagnostics in Diagnosis and Management of Patients With Sepsis(2020)54 cited
- → Severity of Disease Correlated With Fever Reduction in Febrile Infants(1989)53 cited
- → Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease(2016)52 cited
- → Treatment of COVID-19 Patients with Convalescent Plasma in Houston, Texas(2020)38 cited